Literature DB >> 33596348

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Danuta M Skowronski1, Gaston De Serres2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33596348     DOI： 10.1056/NEJMc2036242

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  90 in total

1.  Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China.

Authors:  Haisu Yi; Qian Wang; Jiankai Deng; Hengchun Li; Yingkun Zhang; Zhilong Chen; Tianxin Ji; Wenming Liu; Xuehua Zheng; Qinghua Ma; Xinxin Sun; Yudi Zhang; Xuegao Yu; Mengzhang He; Ling Chen; Ying Feng
Journal:  Virol Sin       Date:  2022-06-25       Impact factor: 6.947

2.  Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.

Authors:  Desarey Morales Vasquez; Kevin Chiem; Chengjin Ye; Luis Martinez-Sobrido
Journal:  Methods Mol Biol       Date:  2022

3.  Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan.

Authors:  Keigo Sekihara; Takatoshi Shibasaki; Tatsuya Okamoto; Chihiro Matsumoto; Kuniaki Ito; Kana Fujimoto; Fumito Kato; Wataru Matsuda; Kentaro Kobayashi; Ryo Sasaki; Tatsuki Uemura; Akio Kimura; Haruhito Sugiyama; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2022-04-30

4.  A Testing and Quarantine Algorithm for Individual International Travelers Using Published Data on WHO-Approved Vaccines and Bayes' Theorem.

Authors:  FuShiuan Whitney Lee; Jamie Wang; C Jason Wang
Journal:  Vaccines (Basel)       Date:  2022-06-06

5.  Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.

Authors:  Santiago Romero-Brufau; Ayush Chopra; Alex J Ryu; Esma Gel; Ramesh Raskar; Walter Kremers; Karen S Anderson; Jayakumar Subramanian; Balaji Krishnamurthy; Abhishek Singh; Kalyan Pasupathy; Yue Dong; John C O'Horo; Walter R Wilson; Oscar Mitchell; Thomas C Kingsley
Journal:  BMJ       Date:  2021-05-12

6.  Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Chris Robertson; Julia Stowe; Elise Tessier; Ruth Simmons; Simon Cottrell; Richard Roberts; Mark O'Doherty; Kevin Brown; Claire Cameron; Diane Stockton; Jim McMenamin; Mary Ramsay
Journal:  BMJ       Date:  2021-05-13

7.  A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.

Authors:  Alexandra Tauzin; Manon Nayrac; Mehdi Benlarbi; Shang Yu Gong; Romain Gasser; Guillaume Beaudoin-Bussières; Nathalie Brassard; Annemarie Laumaea; Dani Vézina; Jérémie Prévost; Sai Priya Anand; Catherine Bourassa; Gabrielle Gendron-Lepage; Halima Medjahed; Guillaume Goyette; Julia Niessl; Olivier Tastet; Laurie Gokool; Chantal Morrisseau; Pascale Arlotto; Leonidas Stamatatos; Andrew T McGuire; Catherine Larochelle; Pradeep Uchil; Maolin Lu; Walther Mothes; Gaston De Serres; Sandrine Moreira; Michel Roger; Jonathan Richard; Valérie Martel-Laferrière; Ralf Duerr; Cécile Tremblay; Daniel E Kaufmann; Andrés Finzi
Journal:  Cell Host Microbe       Date:  2021-06-04       Impact factor: 21.023

8.  Reply to "How important is the second dose of the COVID-19 mRNA vaccine?"

Authors:  Marcus S Shaker; Elizabeth Phillips; Kimberly G Blumenthal; Elissa M Abrams; Aleena Banerji; John Oppenheimer; Timothy K Vander Leek; Douglas P Mack; Paige G Wickner; Alexander G Singer; David A Khan; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06

Review 9.  The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach.

Authors:  Matthew Greenhawt; Elissa M Abrams; Marcus Shaker; Derek K Chu; David Kahn; Cem Akin; Waleed Alqurashi; Peter Arkwright; James L Baldwin; Moshe Ben-Shoshan; Jonathan Bernstein; Theresa Bingeman; Katerina Blumchen; Aideen Byrne; Antonio Bognanni; Dianne Campbell; Ronna Campbell; Zain Chagla; Edmond S Chan; Jeffrey Chan; Pasquale Comberiatti; Timothy E Dribin; Anne K Ellis; David M Fleischer; Adam Fox; Pamela A Frischmeyer-Guerrerio; Remi Gagnon; Mitchell H Grayson; Caroline C Horner; Johnathan Hourihane; Constance H Katelaris; Harold Kim; John M Kelso; David Lang; Dennis Ledford; Michael Levin; Jay Lieberman; Richard Loh; Doug Mack; Bruce Mazer; Gissele Mosnaim; Daniel Munblit; S Shahzad Mustafa; Anil Nanda; John Oppenheimer; Kirsten P Perrett; Allison Ramsey; Matt Rank; Kara Robertson; Javed Shiek; Jonathan M Spergel; David Stukus; Mimi Lk Tang; James M Tracy; Paul J Turner; Anna Whalen-Browne; Dana Wallace; Julie Wang; Susan Wasserman; John K Witty; Margitta Worm; Timothy K Vander Leek; David Bk Golden
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-18

Review 10.  Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19).

Authors:  Ting Wu; Shuntong Kang; Wenyao Peng; Chenzhe Zuo; Yuhao Zhu; Liangyu Pan; Keyun Fu; Yaxian You; Xinyuan Yang; Xuan Luo; Liping Jiang; Meichun Deng
Journal:  Front Med (Lausanne)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.